PRVAPrivia Health Group, Inc.

PRVA Stock Price, Valuation & Chart | Privia Health Group, Inc.

Compare

$19.460-0.08 (-0.41%)

At close · 22 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Healthcare Information Services

Overview Financials Dividends Ratios

PRVA Historical price chart

PRVA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.45B

PE Ratio92.67

EPS0.21

Trading Volume1.09M

Today's High/Low19.9/19.43

Dividend Yield0.00

52 Week High/Low28.82/19.42

Shares Outstanding126.01M

PRVA Financial Statement

PRVA Analyst ratings

PRVA Analysis & performance metrics

PRVA Company profile

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health…

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent…

PRVA Management team

Name

Position

Parth MehrotraCEO

Chief Executive Officer & Director

David Mountcastle CPA, MBACFO

Executive Vice President, Chief Financial Officer & Principal Accounting Officer

Chris VoigtCTO

Executive Vice President & Chief Technology Officer

Jenny Harding

Chief People Officer

Jay Stevens

Senior Vice President & Chief Growth Officer

Eric J. Beyer

Executive Vice President of Medical Groups

Robert P. Borchert

Senior Vice President of Investor Relations & Corporate Communications

Edward Christopher Fargis Esq.

Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary

Name

Position

Parth MehrotraCEO

Chief Executive Officer & Director

David Mountcastle CPA, MBACFO

Executive Vice President, Chief Financial Officer & Principal Accounting Officer

Chris VoigtCTO

Executive Vice President & Chief Technology Officer

Jenny Harding

Chief People Officer

Jay Stevens

Senior Vice President & Chief Growth Officer

Eric J. Beyer

Executive Vice President of Medical Groups

Robert P. Borchert

Senior Vice President of Investor Relations & Corporate Communications

Edward Christopher Fargis Esq.

Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary

Management Team

Parth MehrotraCEO

Chief Executive Officer & Director

David Mountcastle CPA, MBACFO

Executive Vice President, Chief Financial Officer & Principal Accounting Officer

Chris VoigtCTO

Executive Vice President & Chief Technology Officer

Jenny Harding

Chief People Officer

Jay Stevens

Senior Vice President & Chief Growth Officer

Eric J. Beyer

Executive Vice President of Medical Groups

Robert P. Borchert

Senior Vice President of Investor Relations & Corporate Communications

Edward Christopher Fargis Esq.

Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary

Management

Parth MehrotraCEO

Chief Executive Officer & Director

David Mountcastle CPA, MBACFO

Executive Vice President, Chief Financial Officer & Principal Accounting Officer

Chris VoigtCTO

Executive Vice President & Chief Technology Officer

Jenny Harding

Chief People Officer

Jay Stevens

Senior Vice President & Chief Growth Officer

Eric J. Beyer

Executive Vice President of Medical Groups

Robert P. Borchert

Senior Vice President of Investor Relations & Corporate Communications

Edward Christopher Fargis Esq.

Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary

Total 8 executives

PRVA Frequently asked questions

What is Privia Health Group, Inc. (PRVA) Stock Price?

Current stock price of Privia Health Group, Inc. (PRVA) stock is $19.460. The stock price is -0.41% lower in the session. The intraday range can be seen from this page. Volume of Privia Health Group, Inc. (PRVA) stock is 1.09M.

Last updated at 22 Sept 2026, 08:00 pm.

Why is the Privia Health Group, Inc. (PRVA) stock price going up or down today?

The stock price of Privia Health Group, Inc. (PRVA) can change with earnings, company news, and overall market sentiment. Privia Health Group, Inc. operates in the Healthcare / Medical - Healthcare Information Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Privia Health Group, Inc. stock expensive at its current price?

Whether Privia Health Group, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRVA on this page is 92.67. EPS on this page is 0.21. Compare those figures with peers and growth expectations before deciding if the current Privia Health Group, Inc. price is justified.

How has the stock price of Privia Health Group, Inc. (PRVA) performed historically?

Historical performance for Privia Health Group, Inc. (PRVA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRVA reacted to past earnings and market events.

Should I buy Privia Health Group, Inc. (PRVA) stock, at this price?

Buying Privia Health Group, Inc. (PRVA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.